IDEAS home Printed from https://ideas.repec.org/p/ohe/occpap/000217.html
   My bibliography  Save this paper

Enhancing the Benefits from Biomedical and Health Research Spillovers

Author

Listed:
  • Office of Health Economics

Abstract

Research spillovers may exist when research by one organisation creates increased output for other organisations that operate in the same or another sector of the economy. Both the mechanisms and the ultimate value of this transfer of ideas, knowledge or know-how still are not fully understood and virtually all such research on spillovers has been focused outside the UK. Given current constraints on public, charitable and private research funding, enhancing spillovers may become an important objective in UK science and technology policy. This OHE Occasional Paper discusses key aspects of spillovers and identifies top priorities for policy research that could help bring spillover effects more explicitly into UK policy decisions.

Suggested Citation

  • Office of Health Economics, 2010. "Enhancing the Benefits from Biomedical and Health Research Spillovers," Occasional Paper 000217, Office of Health Economics.
    • Handle: RePEc:ohe:occpap:000217
    as

    Download full text from publisher

    File URL: https://www.ohe.org/publications/enhancing-benefits-biomedical-and-health-research-spillovers/attachment-333-enhancing_the_benefits_10-2010/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Edwin Mansfield, 1986. "Patents and Innovation: An Empirical Study," Management Science, INFORMS, vol. 32(2), pages 173-181, February.
    2. Office of Health Economics, 2008. "Medical Research: What's It Worth?," Contract Research 000236, Office of Health Economics.
    3. David J. Teece & Gary Pisano & Amy Shuen, 1997. "Dynamic capabilities and strategic management," Strategic Management Journal, Wiley Blackwell, vol. 18(7), pages 509-533, August.
    4. Aldo Geuna & Ammon J. Salter & W. Edward Steinmueller (ed.), 2003. "Science and Innovation," Books, Edward Elgar Publishing, number 2831.
    5. Manuel Trajtenberg & Adam B. Jaffe & Michael S. Fogarty, 2000. "Knowledge Spillovers and Patent Citations: Evidence from a Survey of Inventors," American Economic Review, American Economic Association, vol. 90(2), pages 215-218, May.
    6. Toole, Andrew A, 2007. "Does Public Scientific Research Complement Private Investment in Research and Development in the Pharmaceutical Industry?," Journal of Law and Economics, University of Chicago Press, vol. 50(1), pages 81-104, February.
    7. Ward, Michael R & Dranove, David, 1995. "The Vertical Chain of Research and Development in the Pharmaceutical Industry," Economic Inquiry, Western Economic Association International, vol. 33(1), pages 70-87, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Scherer, F.M., 2010. "Pharmaceutical Innovation," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 539-574, Elsevier.
    2. Penin, Julien, 2005. "Patents versus ex post rewards: A new look," Research Policy, Elsevier, vol. 34(5), pages 641-656, June.
    3. Hanna Hottenrott & Bronwyn H. Hall & Dirk Czarnitzki, 2016. "Patents as quality signals? The implications for financing constraints on R&D," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 25(3), pages 197-217, April.
    4. Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
    5. Choi, Mincheol & Lee, Chang-Yang, 2021. "Technological diversification and R&D productivity: The moderating effects of knowledge spillovers and core-technology competence," Technovation, Elsevier, vol. 104(C).
    6. Jiang He & M. Hosein Fallah, 2014. "Dynamics of Inventor Networks and the Evolution of Technology Clusters," International Journal of Urban and Regional Research, Wiley Blackwell, vol. 38(6), pages 2174-2200, November.
    7. Zhai, Zhe & Ghosal, Vivek, 2022. "Internationalization of innovation and firm performance in the pharmaceutical industry," International Review of Economics & Finance, Elsevier, vol. 80(C), pages 882-905.
    8. Köhler, Christian & Sofka, Wolfgang & Grimpe, Christoph, 2009. "Selectivity in search strategies for innovation: from incremental to radical, from manufacturing to services," ZEW Discussion Papers 09-066, ZEW - Leibniz Centre for European Economic Research.
    9. Giovanni Dosi & Luigi Marengo & Corrado Pasquali, 2010. "How Much Should Society Fuel the Greed of Innovators? On the Relations between Appropriability, Opportunities and Rates of Innovation," Chapters, in: Riccardo Viale & Henry Etzkowitz (ed.), The Capitalization of Knowledge, chapter 4, Edward Elgar Publishing.
    10. Hur, Wonchang & Oh, Junbyoung, 2021. "A man is known by the company he keeps?: A structural relationship between backward citation and forward citation of patents," Research Policy, Elsevier, vol. 50(1).
    11. Rakesh B. Sambharya & Jooh Lee, 2014. "Renewing Dynamic Capabilities Globally: An Empirical Study of the World’s Largest MNCs," Management International Review, Springer, vol. 54(2), pages 137-169, April.
    12. Burcu Fazlıoğlu & Başak Dalgıç & Ahmet Burçin Yereli, 2019. "The effect of innovation on productivity: evidence from Turkish manufacturing firms," Industry and Innovation, Taylor & Francis Journals, vol. 26(4), pages 439-460, April.
    13. Atul Nerkar & Srikanth Paruchuri, 2005. "Evolution of R&D Capabilities: The Role of Knowledge Networks Within a Firm," Management Science, INFORMS, vol. 51(5), pages 771-785, May.
    14. Deepak Somaya & Ian O. Williamson & Xiaomeng Zhang, 2007. "Combining Patent Law Expertise with R&D for Patenting Performance," Organization Science, INFORMS, vol. 18(6), pages 922-937, December.
    15. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    16. Emmanuel Dechenaux & Brent Goldfarb & Scott Shane & Marie Thursby, 2008. "Appropriability and Commercialization: Evidence from MIT Inventions," Management Science, INFORMS, vol. 54(5), pages 893-906, May.
    17. Francesco Paolo Appio & Fabrizio Cesaroni & Alberto Minin, 2014. "Visualizing the structure and bridges of the intellectual property management and strategy literature: a document co-citation analysis," Scientometrics, Springer;Akadémiai Kiadó, vol. 101(1), pages 623-661, October.
    18. Chung-Jen Chen & Bou-Wen Lin & Jun-You Lin & Yung-Chang Hsiao, 2020. "Learning-from-parents: exploitative knowledge acquisition and the innovation performance of joint venture," The Journal of Technology Transfer, Springer, vol. 45(1), pages 228-258, February.
    19. Samaniego, Roberto M., 2013. "Knowledge spillovers and intellectual property rights," International Journal of Industrial Organization, Elsevier, vol. 31(1), pages 50-63.
    20. Haschka, Rouven E. & Herwartz, Helmut, 2020. "Innovation efficiency in European high-tech industries: Evidence from a Bayesian stochastic frontier approach," Research Policy, Elsevier, vol. 49(8).

    More about this item

    Keywords

    Enhancing the Benefits from Biomedical and Health Research Spillovers;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:occpap:000217. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.